New research shows that extreme weight loss and weight gain significantly increase the risk of death in obese individuals with cardiovascular disease.

A study finds that significant weight loss increases the risk for individuals with cardiovascular disease. New research has ...

Research published in Nature determined why obese individuals who lose weight tend to regain the weight over time. Here's how ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

New research has found for the first time that extreme weight fluctuations in obese individuals with cardiovascular disease ...

One late-night meal or midnight snack isn't going to derail your weight loss or cause weight gain. Regularly eating late at ...

This form of exercise is found to be especially beneficial for women and middle-aged and older adults, particularly those ...

Certified trainers said the best time of day to exercise for weight loss is the time you’ll stick with Morning exercisers may ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

Very few people are currently being prescribed drugs for weight loss on the NHS in Scotland, research by BBC Scotland News ...

The challenge of the obesity epidemic is widespread and one that even pediatricians face constantly,” a Connecticut doctor ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.